Citation: H. Fischer et al., BLOOD-BRAIN-BARRIER PERMEATION - MOLECULAR-PARAMETERS GOVERNING PASSIVE DIFFUSION, The journal of membrane biology, 165(3), 1998, pp. 201-211
Authors:
GOTTSCHLICH R
BARBER A
BARTOSZYK GD
SEYFRIED CA
Citation: R. Gottschlich et al., THE PERIPHERALLY ACTING KAPPA-OPIATE AGONIST EMD-61753 AND ANALOGS - OPIOID ACTIVITY VERSUS PERIPHERAL SELECTIVITY, Drugs under experimental and clinical research, 21(5), 1995, pp. 171-174
Authors:
GOTTSCHLICH R
ACKERMANN KA
BARBER A
BARTOSZYK GD
GREINER HE
Citation: R. Gottschlich et al., EMD-61753 AS A FAVORABLE REPRESENTATIVE OF STRUCTURALLY NOVEL ARYLACETAMIDO-TYPE-KAPPA OPIATE RECEPTOR AGONISTS, Bioorganic & medicinal chemistry letters, 4(5), 1994, pp. 677-682
Citation: R. Gottschlich et al., K-OPIOID ACTIVITY OF THE 4 STEREOISOMERS OF THE PERIPHERALLY SELECTIVE K-AGONISTS, EMD-60-400 AND EMD-61-753, Chirality, 6(8), 1994, pp. 685-689
Citation: A. Seelig et al., A METHOD TO DETERMINE THE ABILITY OF DRUGS TO DIFFUSE THROUGH THE BLOOD-BRAIN-BARRIER, Proceedings of the National Academy of Sciences of the United Statesof America, 91(1), 1994, pp. 68-72
Authors:
BARBER A
BARTOSZYK GD
BENDER HM
GOTTSCHLICH R
GREINER HE
HARTING J
MAULER F
MINCK KO
MURRAY RD
SIMON M
SEYFRIED CA
Citation: A. Barber et al., A PHARMACOLOGICAL PROFILE OF THE NOVEL, PERIPHERALLY-SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, EMD-61753, British Journal of Pharmacology, 113(4), 1994, pp. 1317-1327
Authors:
BARBER A
BARTOSZYK GD
GREINER HE
MAULER F
MURRAY RD
SEYFRIED CA
SIMON M
GOTTSCHLICH R
HARTING J
LUES I
Citation: A. Barber et al., CENTRAL AND PERIPHERAL ACTIONS OF THE NOVEL KAPPA-OPIOID RECEPTOR AGONIST, EMD-60400, British Journal of Pharmacology, 111(3), 1994, pp. 843-851